Your browser doesn't support javascript.
loading
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery.
Peterhoff, David; Thalhauser, Stefanie; Sobczak, Jan M; Mohsen, Mona O; Voigt, Christoph; Seifert, Nicole; Neckermann, Patrick; Hauser, Alexandra; Ding, Song; Sattentau, Quentin; Bachmann, Martin F; Breunig, Miriam; Wagner, Ralf.
Affiliation
  • Peterhoff D; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, Germany.
  • Thalhauser S; Institute of Clinical Microbiology and Hygiene, University Hospital Regensburg, 93053 Regensburg, Germany.
  • Sobczak JM; Institute of Pharmaceutical Technology, University of Regensburg, 93053 Regensburg, Germany.
  • Mohsen MO; Department for BioMedical Research, University of Bern, 3010 Bern, Switzerland.
  • Voigt C; Department of Immunology RI, University Hospital Bern, 3010 Bern, Switzerland.
  • Seifert N; Department for BioMedical Research, University of Bern, 3010 Bern, Switzerland.
  • Neckermann P; Department of Immunology RI, University Hospital Bern, 3010 Bern, Switzerland.
  • Hauser A; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, Germany.
  • Ding S; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, Germany.
  • Sattentau Q; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, Germany.
  • Bachmann MF; Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, Germany.
  • Breunig M; EuroVacc Foundation, 1002 Lausanne, Switzerland.
  • Wagner R; Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.
Vaccines (Basel) ; 9(6)2021 Jun 11.
Article in En | MEDLINE | ID: mdl-34208059
ABSTRACT
The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm and 200 nm silica nanoparticles (SiNPs) to optimize conjugation density and attachment stability. Env was redesigned to enable site-specific cysteine-mediated covalent conjugation while maintaining its structural integrity and antigenicity. Env was anchored to different sized SiNPs with a calculated spacing of 15 nm between adjacent trimers. Both particle sizes exhibited high in vitro stability over a seven-day period. After attachment, 100 nm particles showed better colloidal stability compared to 200 nm particles. Importantly, the antigenic profile of Env was not impaired by surface attachment, indicating that the quaternary structure was maintained. In vitro Env uptake by dendritic cells was significantly enhanced when Env was delivered on the surface of nanoparticles compared to soluble Env. Furthermore, multivalent Env displayed efficiently activated B cells even at Env concentrations in the low nanomolar range. In mice, antibody responses to nanoparticle-coupled Env were stronger compared to the free protein and had equivalent effects at lower doses and without adjuvant.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Vaccines (Basel) Year: 2021 Document type: Article Affiliation country: